Paul Cremer, MD

General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Sobhi Pharmaceutical (MODEST), Kiniksa(MODEST) RESEARCH/RESEARCH GRANTS: Novartis(SIGNIFICANT), Kiniksa(SIGNIFICANT)

View Full Disclosure